http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1531897-A4

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d20a83d0eb2b93a5325fbea732158423
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-407
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4824
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-04
filingDate 2003-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d6634b46c0dd9552e0fdda87e932e99
publicationDate 2008-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1531897-A4
titleOfInvention A METHOD FOR EXPLOITING PAIN OF CENTRAL ORIGIN FOR RESULTING FROM A BACKMARK INJURY
abstract Methods are provided to reliably identify (110) and surgically eradicate (116) aberrant DREZ in patients suffering from spinal cord injury. The methods include identifying potential aberrant DREZ using a combination of mapping techniques based on the location of the patients perceived pain, analysis of the spontaneous electrical hyperactivity in targeted DREZ, and analysis of evoked transcutaneous C-fiber stimulation both in pre-operative and operative conditions. Methods are also provided for identifying potential pain effecters in aberrant DREZ, useful in the preparation of non-invasive therapeutics for central pain characteristic of spinal cord injury.
priorityDate 2002-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0236513-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP41520
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44600
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID617510
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01356
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23362
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0C229
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID45845
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID885
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID378611
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01355
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3446
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2803
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP68126
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9PU41
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID109631669
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO57312
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP68125
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP80345
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9PU29
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2802
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409107
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8767
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397536
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA0A1D5NVX6
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399567
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409108
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP06307
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP80344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2284
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226424351
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID25298
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID12424
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09240
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID192656
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO93464
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF6VQX7

Total number of triples: 51.